Trial intelligence / Profile preview

Progesterone for Maintenance Tocolysis

NCT00946088Phase 3Terminated

Sponsor
Stanford University
Start
Oct 2009
Primary completion
Feb 2013
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of progesterone in Preterm labor (PTL), sponsored by Stanford University. Primary endpoint: Reduction in Delivery Rate Prior to 37 Weeks Gestation. Started Oct 2009; status: terminated.

02

Drugs

progesterone
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on NCT00946088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00946088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call